EPG Health
EPG Health is the publisher of Medthority (www.medthority.com), a disease and medicines knowledge base for healthcare professionals worldwide that supports informed treatment decisions for better patient outcomes.
Cutting through the noise for busy HCPs with immersive and personalised journeys through clinically relevant medical education, Medthority is designed to reach target HCP audiences, engage them with trusted, behaviour-changing scientific content, and measure the impact.
Independent or sponsor-led, solutions are individually tailored to address specific learning objectives and report meaningful outcomes aligned to these, informing continuous and evolving educational needs.
Medthority has a global actionable reach of 1.8 million HCPs.
Healthcare Consultancy Group
In a time of transformation, Healthcare Consultancy Group (HCG) is reimagining medical communications. HCG is a global leader in medical communications, powered by distinct agencies united in a common vision: to accelerate product understanding and acceptance, bringing clients’ medicines closer to the patients who need them. Driven by curiosity, powered by innovation, and fuelled by the collaboration, we work with work with pharma and biotech medical affairs, commercial, publications and regulatory teams from early development to post-launch to shape scientific stories with messages that resonate, to engage HCPs with meaningful content and creative expression, and to reach your audience with personalization to truly engage.
In an industry first, HCG has won the coveted “Agency of the Year for Medical Communications, education or Affairs” award at the 2023 Medical Marketing & Media (MM+M) Awards, alongside the prestigious “Medical Affairs Agency of the Year Award” won this summer at the international 2023 Communique Awards. HCG is unique in being the only organization to win Agency of the Year awards in its field on both sides of the Atlantic.
IPG Health
IPG Health Medical Communications is home to the world’s most celebrated and awarded medical communications agencies, united by a healthy obsession to create exceptional medical communications for our clients in the pharmaceutical, biotechnology and related sectors. With over 800 experts across our 8 specialized agencies around the world–AREA23 on Hudson, Caudex, CMC Affinity, CMC Connect, Complete HealthVizion, Complete Regulatory, ProHealth, and Trio–IPG Health Medical Communications collectively presents an unparalleled interconnectivity of medical communications capabilities.
Our connected global network of expert Medical Communications agencies add value directly for their respective clients while also having the agility to integrate with each other, and with other disciplines and specialists across IPG Health to best meet specific client needs. Our ability to combine true expertise, scale and diversity is what sets us apart. We integrate talent and capability from across our agencies to provide customized teams, ensuring the best solution tailored for our clients, and opportunities tailored for our people..
IQVIA
As a global human data science company IQVIA is at the forefront of unlocking the potential of health data to drive key advancements for future health improvements and delivering transformative benefits to improved population outcomes. IQVIA believes that the value of unlocking data is in the clinical and strategic decision-making it can inform and, as a trusted partner to health systems and providers, we use our extensive data and analytics capabilities to transform health outcomes and deliver pioneering biomedical research.
An example of this is how, through using our data analytics capabilities and clinical expertise, we have risk assessed populations and implemented targeted interventions, resulting in reduced emergency admissions and improved patient outcomes – addressing a key challenge faced by all health systems.
95% NHS organisations already use one or more of our services including costing, coding, benchmarking and data warehousing and our insights and feedback expertise is widespread across a range of healthcare systems.
Also, as a major investor in UK life sciences we consistently attract commercial clinical trials in cancer, neurology, paediatrics, and rare disease to the UK, making IQVIA the third largest life sciences employer and contributing over £2.2 billion to the UK economy.
IQVIA’s success is enhanced by creating these valuable connections and collaborations between life sciences and the wider HCS. Our expertise and unique capabilities mean we are best placed to partner with the HCS to deliver improved outcomes.
Let’s Health
We are a marketing and healthcare communication partner, widely experienced in pharmaceutical and healthcare fields, with high focus and orientation service commitment to our clients, partnering with them, in order to develop customized strategies, multidisciplinary, innovative and technological programs to achieve their challenges.
We integrate with our clients developing tailored programs to create value to their internal (salesforce, MSLs, etc.) and external (KOLs, healthcare professionals, nurses, pharmacist, patients) stakeholders through highly efficient and innovative programs, solutions and technologies.
Lucid Group
We are Lucid Group
We are a global healthcare consultancy. We deliver life-transforming value through pioneering solutions that change behaviour, improve clinical practise and advance health outcomes.
Founded in 2007, Lucid group has grown from a small UK-based medical education agency to a global healthcare consultancy and employing over 400 people with several offices in the UK and US.
We are pioneers transforming the world of healthcare communications, shaping the industry and helping our clients to achieve more.
Through a relentless pursuit to increase the impact of our work, we pioneered the use of health psychology within medical communications to influence behaviour change, the impact was game- changing and demonstrated a paradigm shift in disease management and health outcomes.
We create deep, durable partnerships with our ambitious clients to inspire change by creating and designing compelling experiences that empower the audience to learn, understand and act. Delivering life-transforming value for everyone.
Together we transform lives. Always
Medscape Medical Affairs
Medscape Medical Affairs partners with Medical Affairs teams throughout a product’s lifecycle. We facilitate optimal collaboration between internal teams, physicians, and the broader medical community, connecting you directly with Medscape’s 6.5M+ active physician members worldwide.
Origins
Origins creates and delivers patient focused strategy, insights, data, and solutions, which guides pharma and biotech companies to improve value by involving patients throughout the entire product life cycle.
We are passionate about ensuring the patient voice is front of mind from drug discovery to commercialisation so that companies can develop products that offer genuine benefits to help people live better with their condition and in doing so increase the value of their products.
Through our strategic expertise, patient research experience, patient experience data knowledge, and commitment to provide inspiring solutions, Origins is the industry-leading patient-focused specialist.
Page & Page and Partners
Page & Page is an independent creative agency specialising in healthcare communications across pharmaceuticals, medical technology, digital health and lifestyle and wellbeing.
We are on a mission to harness the power of imaginative communication to close the healthcare gap and ensure that every individual lives their healthiest possible life.
To achieve this, we blend science and imagination with billions of data points from our behaviour mapping tool, PIRL, to help our clients get ahead by understanding their audiences like never before.
By developing data-informed solutions that meet business objectives, while solving real human problems, we can revolutionise the effectiveness of marketing campaigns and truly elevate healthcare outcomes.
Prime Global
Accelerating life-changing solutions.
Our world needs solutions to its healthcare challenges. Especially now.
This is what drives us at Prime. We partner with the world’s leading names in healthcare and technology, to deliver meaningful solutions, sooner. We are catalysts for life-changing science.
Our people are at the heart of all we do. One diverse, worldwide, highly skilled team, sharing a very real and human, passionate, brave culture. Our fusion of expertise is complete, encompassing high science, award–winning and cutting-edge technology, evidence and data, proven strategy, and visionary creativity.
We build and nurture deep, genuine and long-lasting relationships. The very foundation for success, within our business and far beyond.
Prime offers an unparalleled ability to understand your challenges and respond with true innovation. Our experienced leaders anticipate the needs of the sector, enabling Prime to proactively evolve. This insight and adaptability is combined with a resolute commitment by our people to deliver the highest quality across the full spectrum of our operations.
Together we accelerate life–changing solutions to global healthcare challenges.
Together, we are Prime.
Recordati Rare Diseases
At Recordati Rare Diseases, we focus on the few – those affected by rare diseases. We believe that every single patient has the right to the best possible treatment. Patients with rare diseases are our top priority. They are at the core of our planning, our thinking and our actions.
Recordati Rare Diseases is a pharmaceutical company that provides treatment for patients with rare diseases. Created in 1990, Recordati Rare Diseases is one of the most active companies in the field of rare diseases.
Our specialty rare disease products are marketed directly by Recordati Rare Diseases in Europe, the Middle East, the U.S.A., Canada, Russia, Japan and Australia, in some Latin American countries, and through selected partners in other parts of the world.
Highly trained specialists and a scientific support team are available to collaborate with doctors, healthcare professionals, patients groups and families, to help improve the quality of life for people with rare diseases.
Recordati Rare Diseases is committed to supporting families affected by rare diseases through the research and development of new therapies and the distribution of specific scientific knowledge throughout the medical community.
Visit our website https://www.recordatirarediseases.com/ or follow us on LinkedIn or Twitter for company updates.
Uptake Strategies
We are a global healthcare consultancy with strong values, actively driving uptake across the pharma and biotech industry. Our team is unrelenting in our shared mission to inspire exceptional performance and deliver work that positively changes more patients’ lives.
We transform the impact of our clients’ most critical projects, across planning, strategy, capability and launch. Our success is measured by improving patient outcomes, enhancing competitive or financial performance, and embedding new capabilities or innovations.
CEO, Stephanie Hall founded Uptake in 2005, and has since curated a unique depth and breadth of talent to join her; our consultancy team pairs accomplished senior industry experts with bright project managers to ensure every project is fully bespoke and achieves ultimate ‘Uptake impact’, seamlessly delivered by the best people.
Values and purpose provide strong foundations to support our approach, making ‘inspiring exceptional’ a joyful experience.
